The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public

Latest topics page 25

Topics ordered by most recent activity across all 71 subcategories.

1,535 topics · page 25 of 52

TopicParticipantsRepliesViewsActivity
Older adults, sarcopenia risk, and the trade-off nobody quantifies
Older adults, sarcopenia risk, and the trade-off nobody quantifies — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a person. The published…
VJSATYAJR+103 109 12k 5mo
Non-inferiority margins: how they are chosen and how they are abused — a second dataset
Non-inferiority margins: how they are chosen and how they are abused — a second dataset — setting out what I have, and where I think it stops being reliable. Comparing FLOW ( N Engl J Med , 2024) with…
FTJIRHAAP+32 37 574 5mo
Cardiovascular risk: reading the outcome trials as a set
Cardiovascular risk: reading the outcome trials as a set Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The published…
JMVKEFHJKB 4 12k 5mo
Anxiety in the first weeks: drug, situation, or both — what changed since
Anxiety in the first weeks: drug, situation, or both — what changed since Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a…
BVSMDHHABN+88 95 4.5k 5mo
Why one laboratory's 98.4% and another's 96.1% may not contradict — one year on
Asking directly, because I could not find a straight answer: Why one laboratory's 98.4% and another's 96.1% may not contradict — one year on Working through the identity arithmetic and I would like it…
MSFKJBMRCR+10 14 13k 5mo
Revisiting: What SELECT changed about how semaglutide is discussed, and what it did not
Revisiting: What SELECT changed about how semaglutide is discussed, and what it did not Writing it up because I had to work it out twice and would rather nobody else did. I have seen SURMOUNT-OSA ( N Engl J…
CNACSE 2 1.9k 5mo
An ABAB design with a data table and honest limitations
An ABAB design with a data table and honest limitations Writing it up because I had to work it out twice and would rather nobody else did. Session topic: SURPASS-4 ( Lancet , 2021). Please read it before…
SSDSEF 2 45k 5mo
[2026 update] Reading a supplementary appendix and finding the interesting part
On the subject in the title: Reading a supplementary appendix and finding the interesting part Working notes rather than a conclusion. Comparing SELECT ( N Engl J Med , 2023) with FLOW ( N Engl J Med , 2024)…
KFIDFIOCH+39 44 8.2k 5mo
Why "dose equivalence" between different incretin analogues is a weak concept
Why "dose equivalence" between different incretin analogues is a weak concept I have a specific reason for asking rather than idle curiosity, and the context is below. I have read the maintained page on this…
WVERFYWMB+124 133 11k 5mo
[2026 update] A rising related-substance total over six months: degradation or method drift?
The question in the title: A rising related-substance total over six months: degradation or method drift? I will give what I have already checked below so nobody repeats it. Posting the method first, because…
CDASHKBSL+71 78 34k 5mo
Revisiting: Absolute versus relative contraindications
Revisiting: Absolute versus relative contraindications Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The published…
MHSKWFEGC+11 15 22k 5mo
Seven-day rolling means and why weekly readings mislead — one year on
On the subject in the title: Seven-day rolling means and why weekly readings mislead — one year on Working notes rather than a conclusion. Longitudinal report with the method stated, because a number without…
SLMBTPRVKO+78 88 16k 5mo
Tag proliferation and whether we should prune — what changed since
Tag proliferation and whether we should prune — what changed since — setting out what I have, and where I think it stops being reliable. Nominating something for promotion into the documentation commons. The…
SCHKSSVKHF+5 9 709 5mo
Mass error in ppm: the arithmetic and the caveat
Mass error in ppm: the arithmetic and the caveat Writing it up because I had to work it out twice and would rather nobody else did. Working through the identity arithmetic and I would like it checked.…
KCCIAMCDBV+108 125 1.5k 5mo
[2026 update] Long-time reader, first-time poster
Long-time reader, first-time poster — setting out what I have, and where I think it stops being reliable. Lower-stakes topic, but the sourcing rule still applies if anyone makes a claim. Something adjacent…
CAWFEGFSK+46 50 23k 5mo
Non-inferiority margins: how they are chosen and how they are abused
Posting this under the heading it deserves: Non-inferiority margins: how they are chosen and how they are abused Everything below is what sits behind that. Comparing SURPASS-2 ( N Engl J Med , 2021) with…
NTKCTDOPA+42 46 10k 5mo
Coverage in the US: a map of the usual obstacles
Coverage in the US: a map of the usual obstacles — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what determines the…
GPMYASKHFA+46 50 7.9k 5mo
Storing in the door of the fridge is worse than you think
Storing in the door of the fridge is worse than you think Writing it up because I had to work it out twice and would rather nobody else did. A question about technique rather than about dose. I have been…
JAKSD 2 8.3k 5mo
What I would record differently if I started again — the long version
What I would record differently if I started again — the long version I have a specific reason for asking rather than idle curiosity, and the context is below. Maintenance rather than loss, which is the part…
VMHMRLEVLO+22 26 57k 5mo
Filter needles: when they help and what they cost you
On the subject in the title: Filter needles: when they help and what they cost you Working notes rather than a conclusion. A question about technique rather than about dose. I have been doing the same thing…
FWSFECRMTT+45 50 19k 5mo
Trifluoroacetate content and its consequences
Trifluoroacetate content and its consequences — setting out what I have, and where I think it stops being reliable. A documentation question rather than an analytical one. I have a certificate in front of me…
AIRDRVHFAV+123 134 31k 5mo
Adsorption to container surfaces and to plastics
On the subject in the title: Adsorption to container surfaces and to plastics Working notes rather than a conclusion. A documentation question rather than an analytical one. I have a certificate in front of…
CTSOCWRMML+13 17 4.3k 5mo
Revisiting: Review: an evidence digest and the citation check that delayed it
Revisiting: Review: an evidence digest and the citation check that delayed it — setting out what I have, and where I think it stops being reliable. Nominating something for promotion into the documentation…
JMJTGSSNS+54 58 8.2k 5mo
Coming back to: Pen dose counters: what a click does and does not guarantee
Pen dose counters: what a click does and does not guarantee — setting out what I have, and where I think it stops being reliable. A question about technique rather than about dose. I have been doing the same…
GLEAICLPK 4 105 5mo
Can a home kit substitute for a laboratory report? A careful no
Asking directly, because I could not find a straight answer: Can a home kit substitute for a laboratory report? A careful no I would like to understand what this number means before I repeat it anywhere. A…
WMFKNRVNDO+122 131 1.7k 5mo
Heterogeneity as information rather than as a nuisance
Posting this under the heading it deserves: Heterogeneity as information rather than as a nuisance Everything below is what sits behind that. Session topic: SCALE ( N Engl J Med , 2015). Please read it before…
DFRJMNAN+88 95 1.2k 6mo
Distinguishing a red flag from an inconvenience
Distinguishing a red flag from an inconvenience — setting out what I have, and where I think it stops being reliable. I would like to talk about documentation quality as a signal, separately from product…
ASJMIT 2 38k 6mo
Coming back to: Reconstitution volumes that produce round numbers, tabulated
On the subject in the title: Reconstitution volumes that produce round numbers, tabulated Working notes rather than a conclusion. Practical question with the units stated, because I have seen how quickly…
CDMNC 2 24k 6mo
Follow-up: A supplier that answers analytical questions with restated claims
A supplier that answers analytical questions with restated claims — setting out what I have, and where I think it stops being reliable. A logistics question, since the answers here are usually better than…
CCPYESTCB+74 82 2.8k 6mo
When to stop reading forums, including this one
When to stop reading forums, including this one I have a specific reason for asking rather than idle curiosity, and the context is below. General question, not a request for advice about my own care — I know…
CSTILFHKAA+78 86 47k 6mo